Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Formycon AG
Company

Formycon AG

Tracked across 2 events · 14 articles · First seen Jun 04, 2026 · Last active Jul 14, 2026

Sentiment
30
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
2 10
Business
OneSource-Formycon biosimilar manufacturing partnership
Impact: Formycon adds OneSource to its manufacturing network, supporting its biosimilar pipeline and FYB4Growth strategy with cost-efficient, scalable supply.
Jul 14, 2026 · 7 articles
4 50
Business
Teva launches AHZANTIVE biosimilar in Europe
Impact: Formycon AG has a semi-exclusive commercialization agreement with Sun Pharma for AHZANTIVE in major parts of Europe and Israel.
Jun 04, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Formycon AG live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.